| 000 | 01810 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250518012509.0 | ||
| 264 | 0 | _c20191125 | |
| 008 | 201911s 0 0 eng d | ||
| 022 | _a2379-3708 | ||
| 024 | 7 |
_a10.1172/jci.insight.93936 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBahne, Emilie | |
| 245 | 0 | 0 |
_aMetformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes. _h[electronic resource] |
| 260 |
_bJCI insight _c12 2018 |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAustralia |
| 650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xmetabolism |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucagon-Like Peptide 1 _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetformin _xpharmacology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPostprandial Period |
| 700 | 1 | _aSun, Emily W L | |
| 700 | 1 | _aYoung, Richard L | |
| 700 | 1 | _aHansen, Morten | |
| 700 | 1 | _aSonne, David P | |
| 700 | 1 | _aHansen, Jakob S | |
| 700 | 1 | _aRohde, Ulrich | |
| 700 | 1 | _aLiou, Alice P | |
| 700 | 1 | _aJackson, Margaret L | |
| 700 | 1 | _ade Fontgalland, Dayan | |
| 700 | 1 | _aRabbitt, Philippa | |
| 700 | 1 | _aHollington, Paul | |
| 700 | 1 | _aSposato, Luigi | |
| 700 | 1 | _aDue, Steven | |
| 700 | 1 | _aWattchow, David A | |
| 700 | 1 | _aRehfeld, Jens F | |
| 700 | 1 | _aHolst, Jens J | |
| 700 | 1 | _aKeating, Damien J | |
| 700 | 1 | _aVilsbøll, Tina | |
| 700 | 1 | _aKnop, Filip K | |
| 773 | 0 |
_tJCI insight _gvol. 3 _gno. 23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1172/jci.insight.93936 _zAvailable from publisher's website |
| 999 |
_c29132301 _d29132301 |
||